Invacare stock: buy or sell?
August 22nd, 2019
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide.
Should I buy Invacare stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Invacare stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Invacare stock a buy?
Financial institutions and banks publish stock ratings everyday.At Stocks2.com, we detected 2 ratings published for IVC stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-2-14||Needham & Company LLC||n/a||Buy|
|2019-1-24||Needham & Company LLC||Buy||Buy|
Invacare stock analysis
Invacare shares climbed 4.88% to $5.16 today.
Invacare shares climbed 4.88% to $5.16 today. IVC is retaking the upward trend marking a new rising bottom heading to break out over $6.19.
After sliding a dreadful -28.20% in a week last week, Invacare closed this week at $5.16 and skyrocketed an amazing 11.93%.
Since last week, when IVC stock price broke down the 20-weeks moving avarage line, it slid $-0.75 per share (-12.69%).
Invacare stock price history
Invacare IPO was on May 11th, 1984 at $2.60 per share1. Since then, IVC stock surged a 98.50%, with a yearly average of 2.80%. If you had invested $1,000 in Invacare stock in 1984, it would worth $985.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Invacare stock historical price chart
IVC stock reached 52-week highs on September at $16.41, and all-time highs 2004-12-13 with a price of 49.98.
Invacare stock price target is $15.00How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' IVC stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we found 2 price targets for IVC stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-2-14||Needham & Company LLC||Reiterates||n/a||$15.00||-|
|2019-1-24||Needham & Company LLC||Initiates||n/a||$15.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, Invacare didn't meet the forecasts of the analysts and posted a frightening EPS of $-0.16 per share when experts were expecting $-0.39.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Invacare annual turnover remained stable a tiny 0.61% to $972.35 million USD from $966.50 marked in 2017. Slightly better, its income margin (compared to revenues) appreciated to -4.52%, that is $-43.92 million.
|2013||$1,350 M||-||$-51.00 M-3.8%||-|
|2014||$1,270 M||-5.91%||$-56.07 M-4.4%||9.94%|
|2015||$1,142 M||-10.06%||$-26.19 M-2.3%||-53.29%|
|2016||$1,047 M||-8.30%||$-42.86 M-4.1%||63.63%|
|2017||$966 M||-7.73%||$-76.54 M-7.9%||78.60%|
|2018||$972 M||0.61%||$-43.92 M-4.5%||-42.62%|
Quarterly financial resultsInvacare reported $244.58 million in sales for 2018-Q4, a 0.01% improvement compared to previous quarter. Reported quarter income marked $-1.25 million with a profit margin of -0.51%. Profit margin gained a 4.41% compared to previous quarter when profit margin was -4.92%. When comparing turnover to same quarter last year, Invacare sales marked a bad loss and depreciated a -2.31%.
|2017-Q1||$232 M||-||$-16.78 M-7.2%||-|
|2017-Q2||$234 M||0.87%||$-23.51 M-10.1%||40.11%|
|2017-Q3||$251 M||7.37%||$-18.59 M-7.4%||-20.92%|
|2017-Q4||$250 M||-0.22%||$-17.66 M-7.1%||-5.00%|
|2018-Q1||$237 M||-5.31%||$-14.11 M-6.0%||-20.12%|
|2018-Q2||$246 M||3.84%||$-16.54 M-6.7%||17.26%|
|2018-Q3||$245 M||-0.65%||$-12.03 M-4.9%||-27.30%|
|2018-Q4||$245 M||0.01%||$-1.25 M-0.5%||-89.65%|
Invacare ownershipWhen you are planning to invest in a stock, it's always worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Invacare, 3.46% of all outstanding shares are owned by its staff.
Bearish positions for IVC stock account 0.00%, no big difference from last month.
For a better context understanding, the following table shows ownership data compared to other related companies:
|Market cap||$174.2 M||$6.1 M||$7.0 B||$949.3 M||$303.4 M|
|Total shares||33.8 M||4.0 M||66.7 M||21.9 M||62.9 M|
|Float shares||32.8 M||3.4 M||66.6 M||18.2 M||60.5 M|
|- Institutional holdings (%)||124.2%||11.2%||86.3%||109.7%||98.2%|
|- Insider holdings (%)||3.5%||62.9%||0.1%||1.2%||3.5%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Thursday, August 22nd, 2019|
|Day range||$4.85 - $5.32|
|Average true range||$0.53|
|50d mov avg||$5.03|
|100d mov avg||$5.89|
|200d mov avg||$6.21|
Invacare performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Invacare against Allied Healthcare Products, Hill-Rom, Inogen, Owens & Minor, Sonoma Pharmaceuticals, Stryker and Teleflex in the following table:
|OMIOwens & Minor||38.51%||-24.33%||-70.27%|